ID   AOXA_RAT                Reviewed;        1333 AA.
AC   Q9Z0U5; Q9R240;
DT   15-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   27-MAR-2024, entry version 172.
DE   RecName: Full=Aldehyde oxidase 1 {ECO:0000312|RGD:620528};
DE            EC=1.2.3.1 {ECO:0000250|UniProtKB:O54754};
DE   AltName: Full=Azaheterocycle hydroxylase 1 {ECO:0000305|PubMed:9224775};
DE            EC=1.17.3.- {ECO:0000269|PubMed:9224775};
GN   Name=Aox1 {ECO:0000312|RGD:620528}; Synonyms=Ao;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, BLOCKAGE OF
RP   N-TERMINUS, HOMODIMER, AND VARIANTS 119-GLY-MET-120 DELINS ALA-ARG;
RP   THR-649; LEU-1276 AND ARG-1315.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9920943; DOI=10.1074/jbc.274.6.3878;
RA   Wright R.M., Clayton D.A., Riley M.G., McManaman J.L., Repine J.E.;
RT   "cDNA cloning, sequencing, and characterization of male and female rat
RT   liver aldehyde oxidase (rAOX1). Differences in redox status may distinguish
RT   male and female forms of hepatic APX.";
RL   J. Biol. Chem. 274:3878-3886(1999).
RN   [2]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, AND KINETIC PARAMETERS.
RX   PubMed=9224775;
RA   Rashidi M.R., Smith J.A., Clarke S.E., Beedham C.;
RT   "In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde
RT   oxidase from human, guinea pig, rabbit, and rat liver.";
RL   Drug Metab. Dispos. 25:805-813(1997).
RN   [3]
RP   FUNCTION IN SUPEROXIDE PRODUCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, HOMODIMER, AND COFACTOR.
RX   PubMed=17353002; DOI=10.1016/j.abb.2006.12.032;
RA   Kundu T.K., Hille R., Velayutham M., Zweier J.L.;
RT   "Characterization of superoxide production from aldehyde oxidase: an
RT   important source of oxidants in biological tissues.";
RL   Arch. Biochem. Biophys. 460:113-121(2007).
RN   [4]
RP   FUNCTION IN NITRIC OXIDE PRODUCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ACTIVITY REGULATION.
RX   PubMed=19801639; DOI=10.1074/jbc.m109.019125;
RA   Li H., Kundu T.K., Zweier J.L.;
RT   "Characterization of the magnitude and mechanism of aldehyde oxidase-
RT   mediated nitric oxide production from nitrite.";
RL   J. Biol. Chem. 284:33850-33858(2009).
RN   [5]
RP   IDENTIFICATION OF PARALOGS.
RX   PubMed=23263164; DOI=10.1007/s00018-012-1229-5;
RA   Kurosaki M., Bolis M., Fratelli M., Barzago M.M., Pattini L., Perretta G.,
RA   Terao M., Garattini E.;
RT   "Structure and evolution of vertebrate aldehyde oxidases: from gene
RT   duplication to gene suppression.";
RL   Cell. Mol. Life Sci. 70:1807-1830(2013).
RN   [6]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=23282065; DOI=10.3109/00498254.2012.755228;
RA   Hamzeh-Mivehroud M., Rahmani S., Rashidi M.R., Hosseinpour Feizi M.A.,
RA   Dastmalchi S.;
RT   "Structure-based investigation of rat aldehyde oxidase inhibition by
RT   flavonoids.";
RL   Xenobiotica 43:661-670(2013).
CC   -!- FUNCTION: Oxidase with broad substrate specificity, oxidizing aromatic
CC       azaheterocycles, such as N1-methylnicotinamide, N-methylphthalazinium
CC       and phthalazine, as well as aldehydes, such as benzaldehyde, retinal,
CC       pyridoxal, and vanillin. Plays a role in the metabolism of xenobiotics
CC       and drugs containing aromatic azaheterocyclic substituents.
CC       Participates in the bioactivation of prodrugs such as famciclovir,
CC       catalyzing the oxidation step from 6-deoxypenciclovir to penciclovir,
CC       which is a potent antiviral agent. Is probably involved in the
CC       regulation of reactive oxygen species homeostasis. Is a prominent
CC       source of superoxide generation via the one-electron reduction of
CC       molecular oxygen. Also catalyzes nitric oxide (NO) production; under
CC       anaerobic conditions, reduces nitrite to NO with NADH or aldehyde as
CC       electron donor, but under aerobic conditions, NADH is the preferred
CC       substrate. These reactions may be catalyzed by several isozymes. May
CC       play a role in adipogenesis. {ECO:0000269|PubMed:17353002,
CC       ECO:0000269|PubMed:19801639, ECO:0000269|PubMed:23282065,
CC       ECO:0000269|PubMed:9224775, ECO:0000269|PubMed:9920943}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + O2 = a carboxylate + H(+) + H2O2;
CC         Xref=Rhea:RHEA:16829, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:17478,
CC         ChEBI:CHEBI:29067; EC=1.2.3.1;
CC         Evidence={ECO:0000250|UniProtKB:O54754};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O2 + retinal = H(+) + H2O2 + retinoate;
CC         Xref=Rhea:RHEA:56736, ChEBI:CHEBI:15035, ChEBI:CHEBI:15036,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240; Evidence={ECO:0000250|UniProtKB:O54754};
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:190135;
CC         Evidence={ECO:0000269|PubMed:17353002};
CC       Note=Binds 2 [2Fe-2S] clusters per subunit.
CC       {ECO:0000269|PubMed:17353002};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17353002};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:17353002};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000250|UniProtKB:O54754};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250|UniProtKB:O54754};
CC   -!- ACTIVITY REGULATION: Inhibited by menadione and isovanillin. Not
CC       inhibited by allopurinol, a xanthine dehydrogenase potent inhibitor.
CC       Inhibited by the flavonoids quercetin, myricetin and genistein. Nitric
CC       oxide generation is inhibited by raloxifene and competitively inhibited
CC       by an increase in oxygen levels. {ECO:0000269|PubMed:19801639,
CC       ECO:0000269|PubMed:23282065, ECO:0000269|PubMed:9224775}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.37 mM for 6-deoxypenciclovir (at 37 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:9224775};
CC         KM=0.08 mM for famciclovir (at 37 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:9224775};
CC         KM=3.0 mM for nitrite {ECO:0000269|PubMed:19801639};
CC         KM=24 uM for NADH {ECO:0000269|PubMed:19801639};
CC         KM=9.6 uM for 4-(dimethylamino)cinnamaldehyde
CC         {ECO:0000269|PubMed:19801639};
CC         Vmax=26 nmol/min/mg enzyme with 6-deoxypenciclovir as substrate
CC         {ECO:0000269|PubMed:9224775};
CC         Vmax=41 nmol/min/mg enzyme with famciclovir as substrate
CC         {ECO:0000269|PubMed:9224775};
CC         Vmax=0.85 umol/sec/mg enzyme for nitrite reduction with NADH as
CC         electron donor {ECO:0000269|PubMed:19801639};
CC         Vmax=1.35 umol/sec/mg enzyme for nitrite reduction with 4-
CC         (dimethylamino)cinnamaldehyde as electron donor
CC         {ECO:0000269|PubMed:19801639};
CC       pH dependence:
CC         Optimum pH is 6.0 for nitrite oxide generation. Activity decreases
CC         below pH 5.0 and above pH 8.0 (PubMed:19801639).
CC         {ECO:0000269|PubMed:19801639};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17353002}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17353002}.
CC   -!- TISSUE SPECIFICITY: Expression in liver (at protein level). Also
CC       detected in heart, lung, spleen and kidney.
CC       {ECO:0000269|PubMed:17353002, ECO:0000269|PubMed:9920943}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- POLYMORPHISM: The sequence variants between males and females could be
CC       due to differences between individual animals, reflect gender
CC       differences or arise from technical problems (PubMed:9920943). The
CC       sequence shown here is that of a Sprague-Dawley female.
CC       {ECO:0000269|PubMed:9920943}.
CC   -!- MISCELLANEOUS: Male and female rats possess kinetically distinct forms
CC       which may be due to differences in redox states.
CC       {ECO:0000305|PubMed:9920943}.
CC   -!- MISCELLANEOUS: AOX genes evolved from a xanthine oxidoreductase
CC       ancestral precursor via a series of gene duplication and
CC       suppression/deletion events. Different animal species contain a
CC       different complement of AOX genes encoding an equivalent number of AOX
CC       isoenzymes. In mammals, the two extremes are represented by certain
CC       rodents such as mice and rats, which are endowed with 4 AOX genes, and
CC       by humans, whose genome is characterized by a single active gene
CC       (PubMed:23263164). {ECO:0000305|PubMed:23263164}.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: The experimental design does not allow to distinguish AOX1
CC       from AOX3 in rat liver as the effector of the superoxide and nitric
CC       oxide production (PubMed:17353002, PubMed:19801639). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF110477; AAD16999.1; -; mRNA.
DR   EMBL; AF110478; AAD17000.1; -; mRNA.
DR   RefSeq; NP_062236.2; NM_019363.3.
DR   AlphaFoldDB; Q9Z0U5; -.
DR   SMR; Q9Z0U5; -.
DR   STRING; 10116.ENSRNOP00000059651; -.
DR   BindingDB; Q9Z0U5; -.
DR   ChEMBL; CHEMBL1641355; -.
DR   iPTMnet; Q9Z0U5; -.
DR   PhosphoSitePlus; Q9Z0U5; -.
DR   PaxDb; 10116-ENSRNOP00000059651; -.
DR   GeneID; 54349; -.
DR   KEGG; rno:54349; -.
DR   UCSC; RGD:620528; rat.
DR   AGR; RGD:620528; -.
DR   CTD; 316; -.
DR   RGD; 620528; Aox1.
DR   eggNOG; KOG0430; Eukaryota.
DR   InParanoid; Q9Z0U5; -.
DR   OrthoDB; 5485853at2759; -.
DR   PhylomeDB; Q9Z0U5; -.
DR   BRENDA; 1.2.3.1; 5301.
DR   Reactome; R-RNO-964975; Vitamin B6 activation to pyridoxal phosphate.
DR   SABIO-RK; Q9Z0U5; -.
DR   PRO; PR:Q9Z0U5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; ISS:UniProtKB.
DR   GO; GO:0004031; F:aldehyde oxidase activity; IDA:RGD.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006805; P:xenobiotic metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   Gene3D; 1.10.150.120; [2Fe-2S]-binding domain; 1.
DR   Gene3D; 3.90.1170.50; Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead; 1.
DR   Gene3D; 3.30.365.10; Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain; 4.
DR   Gene3D; 3.30.390.50; CO dehydrogenase flavoprotein, C-terminal domain; 1.
DR   Gene3D; 3.30.43.10; Uridine Diphospho-n-acetylenolpyruvylglucosamine Reductase, domain 2; 1.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH-like.
DR   InterPro; IPR014313; Aldehyde_oxidase.
DR   InterPro; IPR008274; AldOxase/xan_DH_MoCoBD1.
DR   InterPro; IPR046867; AldOxase/xan_DH_MoCoBD2.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   NCBIfam; TIGR02969; mam_aldehyde_ox; 1.
DR   PANTHER; PTHR11908:SF86; ALDEHYDE OXIDASE; 1.
DR   PANTHER; PTHR11908; XANTHINE DEHYDROGENASE; 1.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   Pfam; PF02738; MoCoBD_1; 1.
DR   Pfam; PF20256; MoCoBD_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF54292; 2Fe-2S ferredoxin-like; 1.
DR   SUPFAM; SSF55447; CO dehydrogenase flavoprotein C-terminal domain-like; 1.
DR   SUPFAM; SSF47741; CO dehydrogenase ISP C-domain like; 1.
DR   SUPFAM; SSF54665; CO dehydrogenase molybdoprotein N-domain-like; 1.
DR   SUPFAM; SSF56176; FAD-binding/transporter-associated domain-like; 1.
DR   SUPFAM; SSF56003; Molybdenum cofactor-binding domain; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; Cytoplasm; FAD; Flavoprotein; Iron; Iron-sulfur; Lipid metabolism;
KW   Metal-binding; Molybdenum; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1333
FT                   /note="Aldehyde oxidase 1"
FT                   /id="PRO_0000166108"
FT   DOMAIN          4..91
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          235..420
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   ACT_SITE        1265
FT                   /note="Proton acceptor; for azaheterocycle hydroxylase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:O54754"
FT   BINDING         43
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         48
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         51
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         73
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         112
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         113
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         116
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         148
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         150
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         150
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         263..270
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         344
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         353
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         357
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         366
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         410
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         801..802
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         1042
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         1083..1086
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         1198
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   BINDING         1263
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   MOD_RES         1063
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06278"
FT   VARIANT         119..120
FT                   /note="GM -> AR (in Sprague-Dawley males; could be
FT                   unrelated to gender)"
FT                   /evidence="ECO:0000269|PubMed:9920943"
FT   VARIANT         649
FT                   /note="A -> T (in Sprague-Dawley males; could be unrelated
FT                   to gender)"
FT                   /evidence="ECO:0000269|PubMed:9920943"
FT   VARIANT         1276
FT                   /note="F -> L (in Sprague-Dawley males; could be unrelated
FT                   to gender)"
FT                   /evidence="ECO:0000269|PubMed:9920943"
FT   VARIANT         1315
FT                   /note="T -> R (in Sprague-Dawley males; could be unrelated
FT                   to gender)"
FT                   /evidence="ECO:0000269|PubMed:9920943"
SQ   SEQUENCE   1333 AA;  146921 MW;  516B6CE395EB05C8 CRC64;
     MDPPQLLFYV NGQKVVENNV DPEMMLLPYL RKNLRLTGTK YGCGGGGCGA CTVMISRYNP
     STKSIRHHPV NACLTPICSL YGTAVTTVEG IGNTRTRLHP VQERIAKCHS TQCGFCTPGM
     VMSMYALLRN HPEPSLDQLT DALGGNLCRC TGYRPIIDAC KTFCRASGCC ESKENGVCCL
     DQGINGSAEF QEGDETSPEL FSEKEFQPLD PTQELIFPPE LMRIAEKQPP KTRVFYSNRM
     TWISPVTLEE LVEAKFKYPG APIVMGYTSV GPEVKFKGVF HPIIISPDRI EELSIINQTG
     DGLTLGAGLS LDQVKDILTD VVQKLPEETT QTYRALLKHL RTLAGSQIRN MASLGGHIVS
     RHLDSDLNPL LAVGNCTLNL LSKDGKRQIP LSEQFLRKCP DSDLKPQEVL VSVNIPCSRK
     WEFVSAFRQA QRQQNALAIV NSGMRVLFRE GGGVIKELSI LYGGVGPTTI GAKNSCQKLI
     GRPWNEEMLD TACRLVLDEV TLAGSAPGGK VEFKRTLIIS FLFKFYLEVL QGLKREDPGH
     YPSLTNNYES ALEDLHSKHH WRTLTHQNVD SMQLPQDPIG RPIMHLSGIK HATGEAIYCD
     DMPAVDRELF LTFVTSSRAH AKIVSIDLSE ALSLPGVVDI ITADHLQDAT TFGTETLLAT
     DKVHCVGQLV CAVIADSETR AKQAAKHVKV VYRDLEPLIL TIEEAIQHKS FFESERKLEC
     GNVDEAFKIA DQILEGEIHI GGQEHFYMET QSMLVVPKGE DGEIDIYVST QFPKHIQDIV
     AATLKLSVNK VMCHVRRVGG AFGGKVGKTS IMAAITAFAA SKHGRAVRCT LERGEDMLIT
     GGRHPYLGKY KVGFMRDGRI VALDVEHYCN GGSSLDESLW VIEMGLLKMD NAYKFPNLRC
     RGWACRTNLP SHTALRGFGF PQAGLVTEAC VTEVAIRCGL SPEQVRTINM YKQIDNTHYK
     QEFSAKTLFE CWRECMAKCS YSERKTAVGK FNAENSWKKR GMAVIPLKFP VGVGSVAMGQ
     AAALVHIYLD GSALVSHGGI EMGQGVHTKM IQVVSRELKM PMSSVHLRGT STETVPNTNA
     SGGSVVADLN GLAVKDACQT LLKRLEPIIS KNPQGTWKDW AQTAFDQSVS LSAVGYFRGY
     ESNINWEKGE GHPFEYFVYG AACSEVEIDC LTGDHKNIRT DIVMDVGHSI NPALDIGQVE
     GAFIQGMGLY TIEELSYSPQ GILYSRGPNQ YKIPAICDIP TEMHISFLPP SEHSNTLYSS
     KGLGESGVFL GCSVFFAIHD AVRAARQERG ISGPWKLTSP LTPEKIRMAC EDKFTKMIPR
     DEPGSYVPWN IPV
//
